Soraya Saïagh

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt et al. · Cancer Immunology Immunotherapy · 2008 · 237 citations · Full text

γ9δ2 T, Cancer Immunosurveillance, Innacell γδ™ +12

Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones

Amir Khammari, Nathalie Labarrière, Virginie Vignard et al. · Journal of Investigative Dermatology · 2009 · 83 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia

Claudia Rössig, Martin Pulé, Bianca Altvater et al. · Leukemia · 2017 · 80 citations

Vaccination, Cell Therapy, Immunology +5

Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy

Thomas Zuliani, Soraya Saïagh, Anne‐Chantal Knol et al. · PLoS ONE · 2013 · 57 citations · Full text

Tissue Engineering, Engineering, Immunology +18

T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells

Géraldine Gallot, Solène Vollant, Soraya Saïagh et al. · Journal of Immunotherapy · 2014 · 50 citations